A06731 Summary:
BILL NO | A06731 |
  | |
SAME AS | SAME AS S04508 |
  | |
SPONSOR | Crespo |
  | |
COSPNSR | Pichardo, Titone, Blake, Joyner, Robinson, Crouch, Rivera, Arroyo, Miller, Palumbo, Seawright, Murray, Otis |
  | |
MLTSPNSR | Duprey, Hevesi, Lopez, McDonough, Simon, Thiele |
  | |
Add S396-rrr, Gen Bus L | |
  | |
Relates to price gouging of medicine. |
A06731 Actions:
BILL NO | A06731 | |||||||||||||||||||||||||||||||||||||||||||||||||
  | ||||||||||||||||||||||||||||||||||||||||||||||||||
04/01/2015 | referred to consumer affairs and protection | |||||||||||||||||||||||||||||||||||||||||||||||||
04/28/2015 | reported referred to codes | |||||||||||||||||||||||||||||||||||||||||||||||||
05/04/2015 | reported | |||||||||||||||||||||||||||||||||||||||||||||||||
05/07/2015 | advanced to third reading cal.330 | |||||||||||||||||||||||||||||||||||||||||||||||||
05/13/2015 | passed assembly | |||||||||||||||||||||||||||||||||||||||||||||||||
05/13/2015 | delivered to senate | |||||||||||||||||||||||||||||||||||||||||||||||||
05/13/2015 | REFERRED TO CONSUMER PROTECTION | |||||||||||||||||||||||||||||||||||||||||||||||||
01/06/2016 | DIED IN SENATE | |||||||||||||||||||||||||||||||||||||||||||||||||
01/06/2016 | RETURNED TO ASSEMBLY | |||||||||||||||||||||||||||||||||||||||||||||||||
01/06/2016 | ordered to third reading cal.254 | |||||||||||||||||||||||||||||||||||||||||||||||||
05/10/2016 | passed assembly | |||||||||||||||||||||||||||||||||||||||||||||||||
05/10/2016 | delivered to senate | |||||||||||||||||||||||||||||||||||||||||||||||||
05/10/2016 | REFERRED TO CONSUMER PROTECTION |
A06731 Committee Votes:
Go to topA06731 Floor Votes:
Yes
Abbate
Yes
Corwin
Yes
Goodell
Yes
Lupardo
ER
Paulin
Yes
Silver
Yes
Abinanti
Yes
Crespo
Yes
Gottfried
Yes
Lupinacci
Yes
Peoples-Stokes
Yes
Simanowitz
Yes
Arroyo
Yes
Crouch
Yes
Graf
Yes
Magee
Yes
Perry
Yes
Simon
Yes
Aubry
Yes
Curran
Yes
Gunther
Yes
Magnarelli
Yes
Persaud
Yes
Simotas
Yes
Barclay
Yes
Cusick
Yes
Hawley
Yes
Malliotakis
Yes
Pichardo
Yes
Skartados
Yes
Barrett
Yes
Cymbrowitz
Yes
Hevesi
ER
Markey
Yes
Pretlow
Yes
Skoufis
Yes
Barron
Yes
Davila
ER
Hikind
Yes
Mayer
Yes
Quart
Yes
Solages
Yes
Benedetto
Yes
DenDekker
Yes
Hooper
Yes
McDonald
Yes
Ra
Yes
Stec
Yes
Bichotte
Yes
Dilan
Yes
Jaffee
Yes
McDonough
Yes
Raia
Yes
Steck
Yes
Blake
Yes
Dinowitz
Yes
Jean-Pierre
Yes
McKevitt
Yes
Ramos
ER
Stirpe
Yes
Blankenbush
No
DiPietro
Yes
Johns
Yes
McLaughlin
Yes
Richardson
Yes
Tedisco
Yes
Borelli
Yes
Duprey
Yes
Joyner
Yes
Miller
Yes
Rivera
No
Tenney
Yes
Brabenec
Yes
Englebright
Yes
Kaminsky
Yes
Montesano
Yes
Roberts
Yes
Thiele
Yes
Braunstein
Yes
Fahy
No
Katz
Yes
Morelle
Yes
Robinson
Yes
Titone
Yes
Brennan
Yes
Farrell
Yes
Kavanagh
Yes
Mosley
Yes
Rodriguez
Yes
Titus
Yes
Brindisi
Yes
Finch
Yes
Kearns
Yes
Moya
Yes
Rosenthal
Yes
Walker
Yes
Bronson
No
Fitzpatrick
Yes
Kim
Yes
Murray
Yes
Rozic
Yes
Walter
ER
Brook-Krasny
No
Friend
Yes
Kolb
No
Nojay
Yes
Russell
Yes
Weinstein
Yes
Buchwald
Yes
Galef
No
Lalor
Yes
Nolan
Yes
Ryan
Yes
Weprin
Yes
Butler
ER
Gantt
Yes
Lavine
Yes
Oaks
Yes
Saladino
Yes
Woerner
Yes
Cahill
Yes
Garbarino
No
Lawrence
Yes
O'Donnell
Yes
Santabarbara
ER
Wozniak
Yes
Ceretto
Yes
Giglio
Yes
Lentol
Yes
Ortiz
Yes
Schimel
Yes
Wright
ER
Clark
Yes
Gjonaj
Yes
Lifton
Yes
Otis
Yes
Schimminger
Yes
Zebrowski
Yes
Colton
Yes
Glick
Yes
Linares
Yes
Palmesano
Yes
Seawright
Yes
Mr. Speaker
Yes
Cook
ER
Goldfeder
Yes
Lopez
Yes
Palumbo
Yes
Sepulveda
‡ Indicates voting via videoconference
Yes
Abbate
Yes
Crespo
Yes
Gottfried
Yes
Lopez
Yes
Palumbo
Yes
Simon
Yes
Abinanti
Yes
Crouch
Yes
Graf
Yes
Lupardo
Yes
Paulin
Yes
Simotas
ER
Arroyo
Yes
Curran
Yes
Gunther
Yes
Lupinacci
Yes
Peoples-Stokes
Yes
Skartados
Yes
Aubry
Yes
Cusick
Yes
Harris
Yes
Magee
Yes
Perry
Yes
Skoufis
Yes
Barclay
Yes
Cymbrowitz
Yes
Hawley
Yes
Magnarelli
Yes
Pichardo
Yes
Solages
Yes
Barrett
ER
Davila
Yes
Hevesi
Yes
Malliotakis
Yes
Pretlow
Yes
Stec
Yes
Barron
Yes
DenDekker
Yes
Hikind
Yes
Markey
Yes
Quart
Yes
Steck
Yes
Benedetto
Yes
Dilan
ER
Hooper
Yes
Mayer
Yes
Ra
Yes
Stirpe
Yes
Bichotte
Yes
Dinowitz
Yes
Hunter
Yes
McDonald
Yes
Raia
Yes
Tedisco
ER
Blake
No
DiPietro
Yes
Hyndman
Yes
McDonough
Yes
Ramos
Yes
Tenney
Yes
Blankenbush
Yes
Duprey
Yes
Jaffee
Yes
McKevitt
Yes
Richardson
Yes
Thiele
ER
Brabenec
Yes
Englebright
Yes
Jean-Pierre
Yes
McLaughlin
Yes
Rivera
Yes
Titone
Yes
Braunstein
Yes
Fahy
Yes
Johns
Yes
Miller
Yes
Robinson
Yes
Titus
Yes
Brennan
Yes
Farrell
Yes
Joyner
Yes
Montesano
Yes
Rodriguez
Yes
Walker
Yes
Brindisi
Yes
Finch
ER
Katz
Yes
Morelle
Yes
Rosenthal
Yes
Walter
Yes
Bronson
No
Fitzpatrick
Yes
Kavanagh
Yes
Mosley
Yes
Rozic
Yes
Weinstein
Yes
Buchwald
No
Friend
Yes
Kearns
Yes
Moya
Yes
Russell
Yes
Weprin
ER
Butler
Yes
Galef
Yes
Kim
Yes
Murray
Yes
Ryan
Yes
Williams
Yes
Cahill
ER
Gantt
ER
Kolb
No
Nojay
Yes
Saladino
Yes
Woerner
Yes
Cancel
Yes
Garbarino
ER
Lalor
Yes
Nolan
Yes
Santabarbara
Yes
Wozniak
Yes
Castorina
Yes
Giglio
Yes
Lavine
Yes
Oaks
Yes
Schimel
Yes
Wright
Yes
Ceretto
ER
Gjonaj
No
Lawrence
Yes
O'Donnell
Yes
Schimminger
Yes
Zebrowski
Yes
Colton
Yes
Glick
Yes
Lentol
Yes
Ortiz
Yes
Seawright
Yes
Mr. Speaker
Yes
Cook
Yes
Goldfeder
Yes
Lifton
Yes
Otis
Yes
Sepulveda
Yes
Corwin
Yes
Goodell
Yes
Linares
Yes
Palmesano
ER
Simanowitz
‡ Indicates voting via videoconference
A06731 Text:
Go to top STATE OF NEW YORK ________________________________________________________________________ 6731 2015-2016 Regular Sessions IN ASSEMBLY April 1, 2015 ___________ Introduced by M. of A. CRESPO, PICHARDO, TITONE, BLAKE, JOYNER, ROBIN- SON, CROUCH, RIVERA, ARROYO, MILLER, PALUMBO -- Multi-Sponsored by -- M. of A. DUPREY, HEVESI, LOPEZ, SIMON, THIELE -- read once and referred to the Committee on Consumer Affairs and Protection AN ACT to amend the general business law, in relation to the price goug- ing of medicine The People of the State of New York, represented in Senate and Assem- bly, do enact as follows: 1 Section 1. The general business law is amended by adding a new section 2 396-rrr to read as follows: 3 § 396-rrr. Price gouging of medicine. 1. For the purposes of this 4 section, "drug subject to a shortage" shall mean any drug or medical 5 product intended for human use publicly reported as being subject to a 6 shortage by the U.S. food and drug administration on its website, 7 provided, however, that a drug or medical product shall only be consid- 8 ered a "drug subject to a shortage" during the period of time that such 9 drug or medical product is listed as being subject to a shortage on such 10 website. 11 2. No party within the chain of distribution of any drug subject to a 12 shortage shall sell or offer to sell any such drug subject to a shortage 13 for an amount which represents an unconscionably excessive price. 14 3. Whether a price is unconscionably excessive is a question of law 15 for the court. 16 (a) The court's determination that a violation of this section has 17 occurred shall be based on any of the following factors: 18 (i) that the amount of the excess in price is unconscionably extreme; 19 (ii) that there was an exercise of unfair leverage or unconscionable 20 means; or 21 (iii) a combination of both factors in subparagraphs (i) and (ii) of 22 this paragraph. EXPLANATION--Matter in italics (underscored) is new; matter in brackets [] is old law to be omitted. LBD00753-01-5A. 6731 2 1 (b) In any proceeding commenced pursuant to subdivision four of this 2 section, prima facie proof that a violation of this section has occurred 3 shall include evidence that: 4 (i) the amount charged represents a gross disparity between the price 5 of the drug subject to a shortage which was the subject of the trans- 6 action and their value measured by the price at which such drug was sold 7 or offered for sale by the defendant in the usual course of business 8 immediately prior to the onset of the shortage; and 9 (ii) the amount charged grossly exceeded the price at which the same 10 or similar drug subject to a shortage was readily obtainable by other 11 purchasers in the trade area. A defendant may rebut a prima facie case 12 with evidence that additional costs not within the control of the 13 defendant were imposed on the defendant for the drug subject to a short- 14 age. 15 4. Where a violation of this section is alleged to have occurred, the 16 attorney general may apply in the name of the People of the State of New 17 York to the supreme court within the judicial district in which such 18 violation is alleged to have occurred, on notice of five days, for an 19 order enjoining or restraining commission or continuance of the alleged 20 unlawful acts. In any such proceeding, the court shall impose a civil 21 penalty in an amount not to exceed one hundred thousand dollars and, 22 where appropriate, order restitution to aggrieved consumers. 23 5. Prior to applying for an order from the supreme court pursuant to 24 subdivision four of this section, the attorney general, in consultation 25 with the department of health, shall consider the pricing dynamics 26 unique to the small and independent distributors within the supply chain 27 including, but not limited to, the price charged by the end use dispen- 28 ser relative to its acquisition cost. 29 § 2. This act shall take effect immediately.